We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$50.8B
AUM Growth
-$294M
Cap. Flow
-$328M
Cap. Flow %
-0.65%
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$255M
2
TXT icon
Textron
TXT
+$206M
3
AZN icon
AstraZeneca
AZN
+$164M
4
XOM icon
ExxonMobil
XOM
+$124M
5
MRNA icon
Moderna
MRNA
+$121M

Sector Composition

Rank Sector Weight
1 Technology 22.3%
2 Healthcare 15.98%
3 Financials 14.49%
4 Consumer Discretionary 11.52%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMS icon
1076
Advanced Drainage Systems
WMS
$11.5B
-175,000
Closed -$20.4M
XP icon
1077
XP
XP
$8.79B
-402,275
Closed -$17.5M
ZS icon
1078
Zscaler
ZS
$26.2B
-25,000
Closed -$5.4M
LENZ
1079
LENZ Therapeutics
LENZ
$164M
-42,857
Closed -$9.22M
TXNM
1080
TXNM Energy Inc
TXNM
$5.93B
-221,053
Closed -$10.8M
GAP
1081
The Gap Inc
GAP
$7.42B
-224,479
Closed -$7.55M
SPRB
1082
Spruce Biosciences
SPRB
$127M
-3,207
Closed -$2.7M
NARI
1083
DELISTED
Inari Medical, Inc. Common Stock
NARI
-85,000
Closed -$7.93M
BHIL
1084
DELISTED
Benson Hill, Inc.
BHIL
-78,543
Closed -$27.2M
OLK
1085
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
-450,000
Closed -$15.5M
VIA
1086
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
-2,695
Closed -$153K
CCV.WS
1087
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
-337,500
Closed -$695K
GFOR.U
1088
DELISTED
Graf Acquisition Corp. IV Units, each consisting of one share of common stock, and one-fifth of one redeemable warrant
GFOR.U
-1,350,000
Closed -$13.4M
PTRA
1089
DELISTED
Proterra Inc. Common Stock
PTRA
-2,000,000
Closed -$34.2M
GRNAW
1090
DELISTED
GreenLight Biosciences Holdings, PBC Warrant
GRNAW
-858,334
Closed -$927K
JUGGU
1091
DELISTED
Jaws Juggernaut Acquisition Corporation Unit
JUGGU
-1,800,000
Closed -$18.1M
LITTU
1092
DELISTED
Logistics Innovation Technologies Corp. Units
LITTU
-2,400,000
Closed -$23.9M
ZTAQU
1093
DELISTED
Zimmer Energy Transition Acquisition Corp. Units
ZTAQU
-2,700,000
Closed -$27.4M
CYXT
1094
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
-1,276,817
Closed -$12.8M
RONI.U
1095
DELISTED
Rice Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RONI.U
-2,700,000
Closed -$27.6M
SKYAU
1096
DELISTED
Skydeck Acquisition Corp. Units
SKYAU
-1,800,000
Closed -$18M
CPARU
1097
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
-1,000,000
Closed -$10.1M
HCICW
1098
DELISTED
Hennessy Capital Investment Corp. V Warrant
HCICW
-175,000
Closed -$427K
VELOW
1099
DELISTED
Velocity Acquisition Corp. Warrant
VELOW
-400,000
Closed -$352K
VELO
1100
DELISTED
Velocity Acquisition Corp. Class A Common Stock
VELO
-1,200,000
Closed -$11.6M

Similar funds

Adage Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
  • Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
  • Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
  • Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
  • Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
  • Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
  • Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.

Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.